PositiveID (PSID) and Development Partner RECEPTORS LLC to Present Their Invention of a Sensing System for an Implantable Glucose Sensor at 11th Annual Diabetes Technology Meeting

DELRAY BEACH, Fla., Oct. 26, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTCBB:PSID), a developer of medical technologies for diabetes management and clinical diagnostics, announced today that its development partner RECEPTORS LLC ("Receptors") will present at the 11th Annual Diabetes Technology Meeting to be held October 27-29 at the Hyatt Regency San Francisco Airport in Burlingame, California.
MORE ON THIS TOPIC